Umit Tapan, MD

Assistant Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Umit Tapan is an Assistant Professor of Medicine at Chobanian and Avedisian School of Medicine and practicing Thoracic Oncologist at Boston Medical Center. His clinical interests are Non-small cell lung cancer, Small cell lung cancer, Mesothelioma, Immunotherapy, Targeted therapy/Precision Medicine. His research interests include Circulating tumor DNA, Gut microbiome and Cancer Immunotherapy, Racial Disparities in Cancer Care and Outcomes.

Dr. Tapan completed his fellowship in Hematology & Oncology at Boston Univesity Medical Center, in which he was Chief Fellow in Hematology & Oncology. Dr. Tapan completed his internship and residency at Steward Carney Hospital. He earned his medical degree from Hacettepe University School of Medicine, Ankara, Turkey.

Publications

  • Published 3/10/2026

    Kim JY, Dirks A, Ford RM, Pai L, Ludwig C, Tapan U. How exclusion criteria can hinder eligibility for lung cancer studies among different racial and ethnic groups. PLOS Digit Health. 2026 Mar; 5(3):e0001262. PMID: 41805924.

    Read at: PubMed

  • Published 1/24/2026

    Martinez CB, Bhatt S, Battaglini J, Beckett A, Tapan U. Lung Cancer in the Incarcerated Population: A Narrative Review. Curr Oncol Rep. 2026 Jan 24; 28(1):2. PMID: 41579227.

    Read at: PubMed

  • Published 1/3/2026

    Battaglini J, AlDoughaim M, Li K, Patel J, Bhatt S, Everett P, Oxnard GR, Tapan U. Real-world adoption of off-label combinations for targeted therapy resistance in non-small cell lung cancer. Clin Transl Oncol. 2026 Jun; 28(6):2428-2434. PMID: 41484568.

    Read at: PubMed

  • Published 9/1/2025

    Wang J, Sajeev G, Chai X, Takundwa R, Dirnberger F, Pundole X, Pastel M, Yang H, Tapan U. Efficacy outcomes between tarlatamab and real-world physicians' choice of therapies for previously treated extensive stage small cell lung cancer. Oncologist. 2025 Sep 01; 30(9). PMID: 40839303.

    Read at: PubMed

  • Published 8/29/2025

    Shah MV, Solem CT, Liao A, Bell KF, Wang Y, Yang H, Meng Y, Ye M, Tapan U. Patient and Physician Preferences for Maintenance Treatment in Advanced Non-Small Cell Lung Cancer: Insights into Treatment Selection. Adv Ther. 2025 Nov; 42(11):5499-5514. PMID: 40879895.

    Read at: PubMed

View All 42 Publications:   View Full Profile in BUMC

Other Positions

  • Member, BU-BMC Cancer Center
    Boston University
  • Member, Evans Center for Interdisciplinary Biomedical Research
    Boston University

Websites

Education

  • Hacettepe University, MD

View all profiles